Showing results (141-150 of 344) with videos related to

Sort By:
Pageof 35
Vaccine|September 29, 1999
Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in childrenT G Boyce, W C Gruber, S D Coleman-Dockery, et al.
Pediatrics|February 1, 1997
Twenty years of outpatient respiratory syncytial virus infection: a framework for vaccine efficacy trialsR G Fisher, W C Gruber, K M Edwards, et al.
Therapeutic Advances in Drug Safety|December 16, 2015
Safety and tolerability of 13-valent pneumococcal conjugate vaccine in healthy Chinese adults, children and infantsFengcai Zhu, Yuemei Hu, Qi Liang, et al.
The American Journal of Emergency Medicine|June 14, 2016
Safety and efficacy of pharmacological cardioversion of recent-onset atrial fibrillation: a single-center experienceR Kriz, M K Freynhofer, T W Weiss, et al.
Vaccine|October 20, 2011
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine (PCV13) when given as a toddler dose to children immunized with PCV7 as infantsE Grimprel, F Laudat, S Patterson, et al.
Vaccine|July 17, 2016
Modeling pneumococcal nasopharyngeal acquisition as a function of anticapsular serum antibody concentrations after pneumococcal conjugate vaccine administrationRon Dagan, Christine Juergens, James Trammel, et al.
American Journal of Diseases of Children (1960)|May 1, 1990
Live attenuated and inactivated influenza vaccine in school-age childrenW C Gruber, L H Taber, W P Glezen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 28, 2013
Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trialRon Dagan, Scott Patterson, Christine Juergens, et al.
Pediatrics|December 31, 1997
Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy childrenW J Rodriguez, W C Gruber, J R Groothuis, et al.
Vaccine|January 15, 2017
PCV13-vaccinated children still carrying PCV13 additional serotypes show similar carriage density to a control group of PCV7-vaccinated childrenRon Dagan, Christine Juergens, James Trammel, et al.
Pageof 35